John M Davis

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc My treatment approach to rheumatoid arthritis
    John M Davis
    Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 87:659-73. 2012
  2. pmc A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis
    John M Davis
    Division of Rheumatology, Department of Medicine, College of Medicine, Mayo Clinic 200 First Street SW, Rochester, MN 55905, USA
    Arthritis Res Ther 14:R24. 2012
  3. pmc Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells
    John M Davis
    Division of Rheumatology, Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Immunol 184:7297-304. 2010
  4. ncbi request reprint Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study
    John M Davis
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 56:820-30. 2007
  5. ncbi request reprint Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases
    John M Davis
    Division of Rheumatology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Clinic, Rochester, Minnesota 55905, USA
    Medicine (Baltimore) 84:208-17. 2005
  6. pmc The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population
    John M Davis
    Mayo Clinic, Rochester, Minnesota, USA
    Arthritis Rheum 58:2603-11. 2008
  7. doi request reprint Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study
    Elena Myasoedova
    Mayo Clinic, Rochester, MN, USA
    Arthritis Rheum 65:1713-8. 2013
  8. pmc Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease
    Cynthia S Crowson
    Mayo Clinic, Rochester, Minnesota, USA
    Arthritis Care Res (Hoboken) 63:729-34. 2011
  9. ncbi request reprint The widening mortality gap between rheumatoid arthritis patients and the general population
    Angel Gonzalez
    Mayo Clinic, Rochester, Minnesota, USA
    Arthritis Rheum 56:3583-7. 2007
  10. pmc A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis
    John M Davis
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 63:1497-506. 2011

Collaborators

Detail Information

Publications29

  1. pmc My treatment approach to rheumatoid arthritis
    John M Davis
    Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 87:659-73. 2012
    ....
  2. pmc A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis
    John M Davis
    Division of Rheumatology, Department of Medicine, College of Medicine, Mayo Clinic 200 First Street SW, Rochester, MN 55905, USA
    Arthritis Res Ther 14:R24. 2012
    ..This study was undertaken to identify profiles of immune response that correlate with radiographic joint damage as a first step toward the discovery of new pathogenic mechanisms of joint destruction in RA...
  3. pmc Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells
    John M Davis
    Division of Rheumatology, Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Immunol 184:7297-304. 2010
    ..Thus, our approach lays the foundation for the development of immunologic "signatures" that could be useful in predicting disease course and monitoring the outcomes of therapy among patients with immune-mediated diseases...
  4. ncbi request reprint Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study
    John M Davis
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 56:820-30. 2007
    ..To determine the relationship between glucocorticoid exposure and cardiovascular (CV) events in patients with rheumatoid arthritis (RA)...
  5. ncbi request reprint Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases
    John M Davis
    Division of Rheumatology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Clinic, Rochester, Minnesota 55905, USA
    Medicine (Baltimore) 84:208-17. 2005
    ..This may represent test bias or false-positive anti-ENA assays or false-negative ANA assays, or may imply immune-related mechanisms not previously described...
  6. pmc The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population
    John M Davis
    Mayo Clinic, Rochester, Minnesota, USA
    Arthritis Rheum 58:2603-11. 2008
    ..To compare the clinical presentation, management, and outcome of heart failure in patients with rheumatoid arthritis (RA) compared with non-RA patients...
  7. doi request reprint Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study
    Elena Myasoedova
    Mayo Clinic, Rochester, MN, USA
    Arthritis Rheum 65:1713-8. 2013
    ....
  8. pmc Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease
    Cynthia S Crowson
    Mayo Clinic, Rochester, Minnesota, USA
    Arthritis Care Res (Hoboken) 63:729-34. 2011
    ..B-type natriuretic peptide (BNP) may be useful to screen for LVDD in the general population. We compared the effectiveness of BNP as a screening tool for LVDD in RA and non-RA subjects without cardiovascular disease (CVD)...
  9. ncbi request reprint The widening mortality gap between rheumatoid arthritis patients and the general population
    Angel Gonzalez
    Mayo Clinic, Rochester, Minnesota, USA
    Arthritis Rheum 56:3583-7. 2007
    ..The purpose of this study was to determine the mortality trends among RA patients compared with those in the general population...
  10. pmc A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis
    John M Davis
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 63:1497-506. 2011
    ..The purpose of this study was to identify a signature of LVDD in patients with RA by analyzing the responsiveness of the innate and adaptive immune systems to stimulation ex vivo...
  11. doi request reprint Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis
    Cynthia S Crowson
    Mayo Clinic, Rochester, Minnesota
    Arthritis Rheum 65:2562-6. 2013
    ..To determine whether the impact of aging on cardiovascular disease (CVD) risk in patients with rheumatoid arthritis (RA) differs from that in the general population (as estimated by the Framingham Risk Score [FRS])...
  12. pmc Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis
    Megan L Krause
    Division of Rheumatology, Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA
    Clin Immunol 141:67-72. 2011
    ..Future studies could utilize this information to devise new biomarkers for the prediction of infection in patients with RA...
  13. pmc The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases
    Cynthia S Crowson
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 63:633-9. 2011
    ....
  14. doi request reprint Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality
    Elena Myasoedova
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
    Curr Rheumatol Rep 12:379-85. 2010
    ..In this review, we summarize the current knowledge of the rates and determinants of mortality in RA, identify and discuss potential explanations for excess mortality, and outline promising research avenues for targeting mortality in RA...
  15. pmc The influence of rheumatoid arthritis disease characteristics on heart failure
    Elena Myasoedova
    Mayo Clinic, Rochester, MN 55905, USA
    J Rheumatol 38:1601-6. 2011
    ..To examine the influence of rheumatoid arthritis (RA) characteristics and antirheumatic medications on the risk of heart failure (HF) in patients with RA...
  16. ncbi request reprint Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease
    Cynthia S Crowson
    Mayo Clinic, Rochester, Minnesota
    Arthritis Care Res (Hoboken) 63:729-34. 2011
    ..B-type natriuretic peptide (BNP) may be useful to screen for LVDD in the general population. We compared the effectiveness of BNP as a screening tool for LVDD in RA and non-RA subjects without cardiovascular disease (CVD)...
  17. pmc Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease
    Cynthia S Crowson
    Department of Health Scienes Research, Division of Rheumatology, Mayo Clinic College of Medicine, MN 55905, USA
    J Rheumatol 38:29-35. 2011
    ..We also examined whether RA disease characteristics are associated with the presence of MetS in RA patients without CVD...
  18. pmc Rheumatoid arthritis and cardiovascular disease
    Cynthia S Crowson
    Mayo Clinic, Rochester, MN
    Am Heart J 166:622-628.e1. 2013
    ..Rheumatoid arthritis (RA) is the most common of the rheumatic diseases and has the best studied relationships with heart disease...
  19. pmc Contribution of obesity to the rise in incidence of rheumatoid arthritis
    Cynthia S Crowson
    Mayo Clinic, Rochester, MN 55905, USA
    Arthritis Care Res (Hoboken) 65:71-7. 2013
    ..In recent years, both the prevalence of obesity and the incidence of RA have been rising. Our objective was to determine whether the "obesity epidemic" could explain the recent rise in the incidence of RA...
  20. pmc Increased prevalence of diastolic dysfunction in rheumatoid arthritis
    Kimberly P Liang
    Department of Health Sciences Research, Mayo Clinic, Mayo Clinic College of Medicine, 200 First Street SW, Rochester MN 55905, USA
    Ann Rheum Dis 69:1665-70. 2010
    ....
  21. ncbi request reprint Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica
    Hilal Maradit Kremers
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 57:279-86. 2007
    ..To examine the effect of glucocorticoid use on the risk of various cardiovascular diseases in patients with polymyalgia rheumatica (PMR)...
  22. pmc In psychosis, cortical interneurons overexpress DNA-methyltransferase 1
    Marin Veldic
    Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois, 1601 West Taylor Street, Chicago, IL 60612, USA
    Proc Natl Acad Sci U S A 102:2152-7. 2005
    ..Interestingly, the DNMT1 increase failed to occur when patients with psychosis received a combination of valproate and APS treatment but not APS monotherapy...
  23. ncbi request reprint Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
    John M Davis
    J Rheumatol 32:1856-62. 2005
  24. ncbi request reprint American College of Neuropsychopharmacology--43rd annual meeting. 12-16 December 2004, San Juan, Puerto Rico
    John M Davis
    Illinois State Psychiatric Institute, Room 309, 1601 West Taylor Street, West Chicago, IL 60612 4397, USA
    IDrugs 8:100-3. 2005
  25. ncbi request reprint Diagnosis and treatment of depression in patients with mental retardation
    David S Janowsky
    Department of Psychiatry, CB 7175, Medical Research Building A, University of North Carolina, Chapel Hill, NC 27599, USA
    Curr Psychiatry Rep 7:421-8. 2005
    ..This article reviews numerous studies elaborating on the diagnosis, phenomenology, and treatment of depression in mentally retarded individuals...
  26. ncbi request reprint S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis
    Alessandro Guidotti
    Department of Psychiatry, Psychiatric Institute, University of Illinois, Chicago, Illinois, USA
    Neuroreport 18:57-60. 2007
    ....
  27. pmc Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder
    Marin Veldic
    Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois, 1601 West Taylor Street, Chicago, IL 60612, United States
    Schizophr Res 91:51-61. 2007
    ..This suggests that different epigenetic mechanisms must exist in the pathogenesis underlying SZ and BDP and implies that these disorders might involve two separate entities that are characterized by a well-defined neuropathology...
  28. pmc The neuropharmacology of psychosis
    Carol A Tamminga
    Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, NE5 110F, Dallas, TX 75390 9127, USA
    Schizophr Bull 33:937-46. 2007
    ..We discuss the kinds of data necessary to further support the dimensional aspects of psychosis...
  29. ncbi request reprint Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis
    Peter D Kent
    Arthritis Rheum 46:2257-8; author reply 2259. 2002